These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19769741)

  • 1. Harnessing dendritic cells to generate cancer vaccines.
    Palucka K; Ueno H; Fay J; Banchereau J
    Ann N Y Acad Sci; 2009 Sep; 1174():88-98. PubMed ID: 19769741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building on dendritic cell subsets to improve cancer vaccines.
    Palucka K; Ueno H; Zurawski G; Fay J; Banchereau J
    Curr Opin Immunol; 2010 Apr; 22(2):258-63. PubMed ID: 20226644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taming cancer by inducing immunity via dendritic cells.
    Palucka AK; Ueno H; Fay JW; Banchereau J
    Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma.
    Palucka AK; Dhodapkar MV; Paczesny S; Burkeholder S; Wittkowski KM; Steinman RM; Fay J; Banchereau J
    J Immunother; 2003; 26(5):432-9. PubMed ID: 12973032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells.
    Paczesny S; Banchereau J; Wittkowski KM; Saracino G; Fay J; Palucka AK
    J Exp Med; 2004 Jun; 199(11):1503-11. PubMed ID: 15173207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased tumor-specific CD8+ T cell induction by dendritic cells matured with a clinical grade TLR-agonist in combination with IFN-gamma.
    Vanderlocht J; Van Elssen CH; Senden-Gijsbers BL; Meek B; Cloosen S; Libon C; Bos GM; Germeraad WT
    Int J Immunopathol Pharmacol; 2010; 23(1):35-50. PubMed ID: 20377993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity.
    Abdel-Wahab Z; DeMatos P; Hester D; Dong XD; Seigler HF
    Cell Immunol; 1998 May; 186(1):63-74. PubMed ID: 9637766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing human dendritic cell subsets to design novel vaccines.
    Banchereau J; Klechevsky E; Schmitt N; Morita R; Palucka K; Ueno H
    Ann N Y Acad Sci; 2009 Sep; 1174():24-32. PubMed ID: 19769733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.
    Banchereau J; Palucka AK; Dhodapkar M; Burkeholder S; Taquet N; Rolland A; Taquet S; Coquery S; Wittkowski KM; Bhardwaj N; Pineiro L; Steinman R; Fay J
    Cancer Res; 2001 Sep; 61(17):6451-8. PubMed ID: 11522640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells: are they clinically relevant?
    Palucka K; Ueno H; Roberts L; Fay J; Banchereau J
    Cancer J; 2010; 16(4):318-24. PubMed ID: 20693842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer vaccines for established cancer: how to make them better?
    Andrews DM; Maraskovsky E; Smyth MJ
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application.
    Trevor KT; Cover C; Ruiz YW; Akporiaye ET; Hersh EM; Landais D; Taylor RR; King AD; Walters RE
    Cancer Immunol Immunother; 2004 Aug; 53(8):705-14. PubMed ID: 15048588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
    J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells and immunity against cancer.
    Palucka K; Ueno H; Fay J; Banchereau J
    J Intern Med; 2011 Jan; 269(1):64-73. PubMed ID: 21158979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic melanoma.
    Palucka AK; Dhodapkar MV; Paczesny S; Ueno H; Fay J; Banchereau J
    J Immunother; 2005; 28(2):158-68. PubMed ID: 15725960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.